Innovating within the regulatory boundaries

18 January 2018 - Deborah Wilkes

Archived

True OTC innovation that steps away from the mainstream will almost certainly encounter regulatory constraints, say James Hall and Harriet Scorer, who are regulatory and medical affairs specialists with OTCexperts. But these constraints can be overcome by supporting innovation with "robust data and evidence", they maintain.

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: